The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CymaBay Therapeutics, Inc. | COMMON STOCK | 23257D103 | 18,366 | 5,905,400 | SH | SOLE | 5,905,400 | 0 | 0 | ||
| Cogent Biosciences, Inc. | COMMON STOCK | 19240Q201 | 22,328 | 2,981,042 | SH | SOLE | 2,981,042 | 0 | 0 | ||
| Chinook Therapeutics, Inc. | COMMON STOCK | 16961L106 | 14,435 | 882,353 | SH | SOLE | 882,353 | 0 | 0 | ||
| Magenta Therapeutics, Inc. | COMMON STOCK | 55910K108 | 6,160 | 2,124,122 | SH | SOLE | 2,124,122 | 0 | 0 | ||
| Zai Lab LTD-ADR | COMMON STOCK | 98887Q104 | 4,178 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
| Aclaris Therapeuitics, Inc. | COMMON STOCK | 00461U105 | 19,739 | 1,144,939 | SH | SOLE | 1,144,939 | 0 | 0 | ||
| Elevation Oncology, Inc. | COMMON STOCK | 28623U101 | 1,399 | 555,000 | SH | SOLE | 555,000 | 0 | 0 | ||
| Aerovate Therapeutics, Inc. | COMMON STOCK | 008064107 | 16,306 | 889,572 | SH | SOLE | 889,572 | 0 | 0 | ||
| Iveric Bio, Inc. | COMMON STOCK | 46583P102 | 42,360 | 2,516,920 | SH | SOLE | 2,516,920 | 0 | 0 | ||
| Viridian Therapeutics Inc | COMMON STOCK | 92790C104 | 24,296 | 1,314,000 | SH | SOLE | 1,314,000 | 0 | 0 | ||
| Tyra Biosciences, Inc. | COMMON STOCK | 90240B106 | 9,592 | 896,418 | SH | SOLE | 896,418 | 0 | 0 | ||
| Alpine Immune Sciences, Inc. | COMMON STOCK | 02083G100 | 9,277 | 1,034,222 | SH | SOLE | 1,034,222 | 0 | 0 | ||
| Akouos, Inc. | COMMON STOCK | 00973J101 | 6,413 | 1,350,006 | SH | SOLE | 1,350,006 | 0 | 0 | ||
| Merus N.V. | COMMON STOCK | N5749R100 | 7,932 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| Entrada Therapeutics, Inc. | COMMON STOCK | 29384C108 | 6,133 | 663,694 | SH | SOLE | 663,694 | 0 | 0 | ||
| Pardes Biosciences, Inc. | COMMON STOCK | 69945Q105 | 1,654 | 229,100 | SH | SOLE | 229,100 | 0 | 0 | ||
| Kura Oncology, Inc. | COMMON STOCK | 50127T109 | 8,143 | 506,423 | SH | SOLE | 506,423 | 0 | 0 | ||
| AnaptysBio, Inc. | COMMON STOCK | 032724106 | 1,448 | 58,515 | SH | SOLE | 58,515 | 0 | 0 | ||
| Tango Therapeutics, Inc. | COMMON STOCK | 87583X109 | 9,509 | 1,254,500 | SH | SOLE | 1,254,500 | 0 | 0 | ||
| Geron Corporation | COMMON STOCK | 374163103 | 19,429 | 14,285,715 | SH | SOLE | 14,285,715 | 0 | 0 | ||